SCHEMBL7993150

SCHEMBL7993150

Cn1c(-c2ccccn2)nc(-c2ccc(C(C)(C)O)nc2)c1Sc1ccc(F)c(F)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 3/20 0.54
GRM5 P41594 1/20 0.41
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPK1 P28482 1/20 0.38
RAB9A P51151 1/20 0.38
KCNH2 Q12809 1/20 0.37
SYK P43405 2/20 0.37
DHFR P00374 1/20 0.37
PDE10A Q9Y233 1/20 0.36
GABRA1 P14867 8/20 0.36
GABRG2 P18507 8/20 0.36
GABRB3 P28472 8/20 0.36
GABRA5 P31644 8/20 0.36
GABRA3 P34903 8/20 0.36
PTGS2 P35354 1/20 0.34
GABRA2 P47869 4/20 0.34
CA12 O43570 1/20 0.33
CA9 Q16790 1/20 0.33
ALOX5AP P20292 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1304088 0.88 FAAH (0.69) FAAHGRM5KCNH2SYKPDE10A
SCHEMBL8004716 0.86 FAAH (0.46) FAAHALDH1A1RAB9AKCNH2SYK
SCHEMBL8003103 0.85 FAAH (0.52) FAAHKDM4EALDH1A1MAPK1RAB9A
SCHEMBL8003107 0.83 FAAH (0.78) FAAHGRM5KDM4EALDH1A1MAPK1
SCHEMBL8011186 0.83 FAAH (0.47) FAAHALDH1A1RAB9AKCNH2SYK
SCHEMBL12106796 0.81 FAAH (0.48) FAAHALDH1A1KCNH2SYKDHFR
SCHEMBL8008181 0.81 FAAH (0.55) FAAHGRM5ALDH1A1KCNH2SYK
SCHEMBL8003243 0.79 FAAH (0.59) FAAHGRM5KDM4EALDH1A1MAPK1
SCHEMBL8002857 0.77 FAAH (0.48) FAAHGRM5KDM4EALDH1A1MAPK1
SCHEMBL8005304 0.76 FAAH (0.65) FAAHGRM5KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8455528-B2 Imidazole derivatives useful as inhibitors of FAAH MERCK SHARP & DOHME CORP. (US) 2013-06-04 US disclosed
US-8455528-B2 Imidazole derivatives useful as inhibitors of FAAH MERCK SHARP & DOHME CORP. (US) 2013-06-04 US disclosed
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-11-03 US disclosed
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-11-03 US disclosed
WO-2009152025-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK & CO., INC. (US) 2009-12-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH FAAH, FAAH2, HNMT FAAH 1/4885GRM5 786/4885KDM4E 534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.